In December, CVS Health entered into a definitive agreement to acquire all outstanding shares of Aetna for approximately $69 billion in cash and stock.
At a special meeting March 13, 98 percent of CVS shareholders’ ballots were in favor of the transaction. Among Aetna shareholders, about 97 percent of votes cast were in favor of the deal.
The parties expect the transaction, which still needs approval from the Department of Justice, to close in the second half of 2018.
More articles on payer issues:
UnitedHealth taps former GlaxoSmithKline CEO to lead Optum: 4 things to know
Some Anthem patients afraid to use ED under new policy: 6 things to know
How health insurers game Medicare Advantage ratings to boost bonus payments
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
